APL-5125
/ Apollo Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 09, 2024
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=100 | Recruiting | Sponsor: Apollo Therapeutics Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Metastases • Appendix Cancer • Biliary Cancer • Breast Cancer • Cholangiocarcinoma • Colorectal Cancer • Endometrial Adenocarcinoma • Endometrial Cancer • Gastric Cancer • Gastrointestinal Cancer • Genito-urinary Cancer • Hepatology • Oncology • Ovarian Cancer • Pancreatic Cancer • Prostate Cancer • Solid Tumor • Triple Negative Breast Cancer
May 06, 2024
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
(clinicaltrials.gov)
- P1/2 | N=100 | Not yet recruiting | Sponsor: Apollo Therapeutics Ltd
Metastases • New P1/2 trial • Appendix Cancer • Biliary Cancer • Breast Cancer • Cholangiocarcinoma • Colorectal Cancer • Endometrial Adenocarcinoma • Endometrial Cancer • Gastric Cancer • Gastrointestinal Cancer • Genito-urinary Cancer • Hepatology • Oncology • Ovarian Cancer • Pancreatic Cancer • Prostate Cancer • Solid Tumor • Triple Negative Breast Cancer
1 to 2
Of
2
Go to page
1